Home » FightingDrugFailure » Training and Advisory Sites

Training and Advisory Sites

Our training and advisory sites have been carefully selected to complement the skill sets provided by our primary partners and to offer students an opportunity to interact with professionals in a variety of settings. Both industry and academic institutions will provide supplemental learning opportunities through a variety of modalities including:

  • On-site training apportunities
  • Seminars conducted at primary partner sites
  • Networking opportunities at international conferences
  • Access to up-to-date technologies and data bases
  • Individual project support and guidance

 

Training Sites

F. Hoffmann-La Roche Ltd., Basel, Switzerland

As a research-focused healthcare company, Roche discovers, develops and provides innovative diagnostic and therapeutic products and services that deliver significant benefits to patients and healthcare professionals – from early detection and prevention of diseases to diagnosis, treatment and treatment monitoring.

Over the past few decades, use of medical biotechnology has led to important advances in diagnostics and therapy. As a result, many diseases can now be detected earlier and treated more specifically than ever before. Biotechnological methods permit the determination of the molecular causes of disease, the development of new diagnostic techniques, and the development of innovative medicines (biopharmaceuticals / therapeutic proteins) directed at specific molecular targets.

F. Hoffmann-La Roche Ltd. will support the Initial Training Network by providing Early Stage Researchers with various learning and networking opportunities.

Website: www.roche.com

CenTrial GmbH, Tübingen, Germany

CenTrial is the contract research company affiliated with the Universities of Tübingen and Ulm. CenTrial is devoted to the complex field of high quality clinical trials and the qualification of specialists for this sector. Clinical trials are an indispensable instrument for collecting reliable data on the pathogenesis, treatment and prevention of diseases. They place high clinical, methodological and ethical demands on everyone involved. Achieving high quality results and findings from clinical trials is an elementary basis for ensuring progress in medicine. CenTrial takes responsibility for accompanying and supporting the content and organization of clinical trials in a Contract Research Organization (CRO) function.

CenTrial will support the Initial Training Network by providing Early Stage Researchers with learning opportunities related to properly conducting clinical trials.

Website: www.centrial.de

 

Advisory Site

Mayo Clinic-NIH Pharmacogenetics Research Network, Rochester, MN, USA

The Pharmacogenetics Research Network (PGRN) is a nationwide collaboration of scientists focused on understanding how genes affect the way a person responds to medications. The long-term goal of the network is to make information available to doctors that will ensure the right dose of the right medicine the first time for everyone.  Since its inception, PGRN scientists have studied genes and medications relevant to a wide range of diseases, including asthma, depression, cancer, and heart disease.

Researchers from the NIH Pharmacogenetics Research Network at the Mayo Clinic will provide Early Stage Researchers with scientific collaboration opportunities as well as invitations to hear invited speakers and attend conferences.

Website: http://mayoresearch.mayo.edu/mayo/research/ppii/

Mayo Clinic-NIH Pharmacogenetics Research Network, Rochester, MN, USA

The Pharmacogenetics Research Network (PGRN) is a nationwide collaboration of scientists focused on understanding how genes affect the way a person responds to medications. The long-term goal of the network is to make information available to doctors that will ensure the right dose of the right medicine the first time for everyone.  Since its inception, PGRN scientists have studied genes and medications relevant to a wide range of diseases, including asthma, depression, cancer, and heart disease.

Researchers from the NIH Pharmacogenetics Research Network at the Mayo Clinic will provide Early Stage Researchers with scientific collaboration opportunities as well as invitations to hear invited speakers and attend conferences.

Website: http://mayoresearch.mayo.edu/mayo/research/ppii/